Pharmacological interference of vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin

Author： Peiro C.   Vallejo S.   Nevado J.   Angulo J.   Llergo J.L.   Cercas E.   Rodrguez-Manas L.   Sanchez-Ferrer C.F.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.386, Iss.2, 1999-12, pp. : 317-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells

By Yamakawa T.   Tanaka S.-i.   Kamei J.   Kadonosono K.   Okuda K.  

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

1 -Adrenoreceptor stimulation causes vascular smooth muscle cell hypertrophy: a possible role for isoprenoid intermediates

By Nishio E.   Kanda Y.   Watanabe Y.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite

Natriuretic peptide receptor‐C‐mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS‐associated signaling

By  

Pharmacology Research & Perspectives, Vol. 6, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deoxyribozymes as Inhibitors of Vascular Smooth Muscle Cell Growth

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 4, 2004-08 ,pp. : 337-339

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the lipoxygenase pathway in phenylephrine-induced vascular smooth muscle cell proliferation and migration

By Nishio E.   Watanabe Y.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite